Title: Ssu-Chia Wang: Innovator in Cancer Treatment
Introduction
Ssu-Chia Wang is an inventor based in New Taipei, Taiwan. He is currently associated with Trineo Biotechnology Co. Ltd. Although he has not yet been granted any patents, his work focuses on innovative methods for treating cancer.
Latest Patent Applications
Ssu-Chia Wang has submitted a patent application titled "Method for Treating a Cancer Associated with the Activation of Galectin-1." This application outlines a method for the treatment and/or prophylaxis of cancer associated with galectin-1. The proposed method involves administering a pharmaceutical composition primarily composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). Additionally, the method includes the option to administer another anti-cancer agent before, together with, or after the administration of the pharmaceutical composition to synergistically suppress cancer growth.
Conclusion
Ssu-Chia Wang is making strides in the field of cancer treatment through his innovative research and patent applications. His work has the potential to contribute significantly to the development of effective cancer therapies.